I am also in at $2.75 with 6000 shares. My cost average is now $3.49. I think we will reach $3.5 in few days once people realize this is trading below cash value. The drug is also not junk either. The trial design was the culprit. The enterprise value is at least few hundred millions. For those who can wait 3 years or longer this will be an excellent investment imo.